Top 10 Growth Companies With High Insider Ownership In South Korea

The South Korean market has displayed promising growth, with a 1.1% increase over the last week and a 3.7% rise over the past year, alongside forecasts predicting annual earnings growth of 29%. Stocks with high insider ownership can be particularly appealing in this environment, as they often indicate strong confidence from those who know the company best.

Here are some top growth companies in South Korea with high insider ownership:

- ALTEOGEN (KOSDAQ:A196170) with 26.6% insider ownership and 73.1% earnings growth.

- Global Tax Free (KOSDAQ:A204620) with 18.1% insider ownership and 72.4% earnings growth.

- Fine M-TecLTD (KOSDAQ:A441270) with 17.3% insider ownership and 36.4% earnings growth.

- Park Systems (KOSDAQ:A140860) with 33.1% insider ownership and 35.8% earnings growth.

- Seojin SystemLtd (KOSDAQ:A178320) with 26.4% insider ownership and 48.1% earnings growth.

Seojin System Co., Ltd. specializes in the manufacture of telecom equipment, repeaters, mechanical products, and LED and other equipment, with a market capitalization of approximately 1.60 billion.

ALTEOGEN Inc.: Potential Undervaluation and Strong Growth

ALTEOGEN Inc., a biopharmaceutical company in South Korea, is trading at a significant discount to its estimated fair value, indicating potential undervaluation. The company is expected to experience robust growth, with earnings projected to increase by 73.06% annually and revenue forecasted to grow at 48.3% per year, surpassing the broader Korean market's growth rates significantly. Despite recent share price volatility and shareholder dilution, ALTEOGEN demonstrates strong fundamentals with very high projected return on equity.

CLASSYS Inc.: Strong Growth and Insider Ownership

CLASSYS Inc., a South Korean company specializing in medical aesthetics devices, has shown strong growth with earnings increasing by 25.9% annually over the past five years. Revenue growth forecasts at 21.3% annually outpace the Korean market's average. Despite recent share price volatility, CLASSYS maintains high insider ownership with a robust return on equity projection.

ST Pharm Co., Ltd.: Undervaluation and Earnings Growth

ST Pharm Co., Ltd., a South Korean company specializing in custom manufacturing services for active pharmaceutical ingredients, is positioned below its estimated fair value, signaling potential undervaluation. The company has demonstrated significant earnings growth over the past five years and is expected to continue growing at a rate that surpasses the market forecast. Despite modest revenue growth projections, ST Pharm Co., Ltd. maintains high insider ownership and shows potential for investment despite recent share price volatility.